Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04055246 · ClinicalTrials.gov registry record · NA
Measuring Effects of Prebiotics on Human Behavior and Cognition
A NA study of Prebiotics and Human Behavior and Cognition, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT04055246: Completed NA study of Prebiotics and Human Behavior and Cognition, sponsored by Duke University.
NCT04055246 is a NA study of Prebiotics and Human Behavior and Cognition that has completed, run by Duke University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04055246, a NA study of Prebiotics and Human Behavior and Cognition, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to test the effects of prebiotics on cognition, behavior and physiology in healthy volunteers.
Primary Outcome
We will measure performance on a ten-domain cognitive battery (score out of 1000 for each domain) and compare the change from baseline between treatment and control groups.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Inulin
- DIETARY_SUPPLEMENT Placebo (maltodextrin)
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-06-04 |
| Est. Completion | 2020-03-23 |
| Phase | NA |
What the finished NCT04055246 record still lists
NCT04055246 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Prebiotics and Human Behavior and Cognition appearing as the primary indexed condition, and to 2 interventions - of which Inulin is the first listed.
NCT04055246 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04055246 about?
NCT04055246 is a clinical study titled "Measuring Effects of Prebiotics on Human Behavior and Cognition". This study is designed to test the effects of prebiotics on cognition, behavior and physiology in healthy volunteers.
What is the current status of trial NCT04055246?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-06-04. Estimated completion is 2020-03-23.
What conditions does trial NCT04055246 study?
This clinical trial studies the following conditions: Prebiotics and Human Behavior and Cognition.
What interventions are being tested in trial NCT04055246?
The interventions under investigation include: Inulin (DIETARY_SUPPLEMENT), Placebo (maltodextrin) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04055246?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04055246 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04055246's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI